BOBO DONALD E JR 4

What Happened
Donald E. Bobo Jr., CVP, Strategy & Corporate Development at Edwards Lifesciences (EW), received equity awards on May 7, 2026 and had shares withheld/disposed to cover tax obligations. He was granted: 7,850 time‑based restricted stock units (RSUs), a target award of 7,850 performance RSUs (0–200% payout depending on performance), and 44,000 stock options. To satisfy tax withholding, 831 shares were disposed at $83.20 ($69,139) and 1,038 shares were disposed at $82.76 ($85,905), totaling about $155,044.

Key Details

• Transaction dates: grants on 2026-05-07; tax‑withholding dispositions on 2026-05-07 and 2026-05-08.
• Prices and amounts withheld: 831 shares @ $83.20 = $69,139; 1,038 shares @ $82.76 = $85,905; total ≈ $155,044.
• Awards: 7,850 time‑based RSUs; 7,850 target performance RSUs (vesting may be 0–200% on May 7, 2029); 44,000 stock options.
• Vesting: time‑based RSUs vest in four equal annual installments beginning one year after grant; options vest monthly after one month over ~36 months; performance RSUs vest at end of three‑year performance period (per footnotes).
• Filing/timeliness: Form 4 filed 2026-05-08 reporting 2026-05-07 transactions (appears timely).
• Filing note: This Form 4 reflects changes in beneficial ownership only and does not list other securities the reporting person may hold.
• Transaction code: F = tax withholding/disposition for taxes; A = award/grant.

Context
These transactions are award grants (acquisitions) combined with routine withholding/dispositions to cover taxes — common when executives receive equity compensation. The RSUs and options vest over time and/or upon performance, so the grants do not represent immediately tradable shares. Tax withholding sales are not the same as a discretionary open‑market sale and typically reflect payroll/tax settlement.